Detection of murine S180 cells expressing a multidrug resistance phenotype using different in vitro test systems and a monoclonal antibody
- PMID: 3314882
Detection of murine S180 cells expressing a multidrug resistance phenotype using different in vitro test systems and a monoclonal antibody
Abstract
Doxorubicin (adriamycin) preconditioned S180 cells were more resistant to doxorubicin. The resistance was detected by three different methods (short-term test, colony assay, tissue culture assay). The doxorubicin-resistant S180 cells express the pleitrop drug resistance phenotype. There exists a multidrug resistance to doxorubicin, dactinomycin (actinomycin D), vincristine and colchicine. In addition, collateral sensitivity was found to fluorouracil (5-fluorouracil) and methotrexate. This multidrug phenotype is in accordance with the pleiotropic phenotype of colchicine-resistant CHO cells. Resistant S180 cells express a glycoprotein of Mr 170 kd determined by indirect immunofluorescence using a monoclonal antibody (Mab 265/F4) to the P-glycoprotein of colchicine-resistant CHO-cells. The P-glycoprotein could be an important prognostic factors for tumors with multidrug resistance.
Similar articles
-
Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4.Anticancer Res. 1988 Jul-Aug;8(4):531-5. Anticancer Res. 1988. PMID: 2902821
-
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.Cancer Res. 1987 May 15;47(10):2594-8. Cancer Res. 1987. PMID: 2436751
-
Induced multidrug-resistance in murine sarcoma 180 cells grown in vitro and in vivo and associated changes in expression of multidrug-resistance DNA-sequences and membrane glycoproteins.Anticancer Res. 1988 Nov-Dec;8(6):1169-78. Anticancer Res. 1988. PMID: 3218953
-
Multidrug-resistance phenotype in Chinese hamster ovary cells.Cancer Treat Rep. 1983 Oct;67(10):869-74. Cancer Treat Rep. 1983. PMID: 6354434 Review.
-
Evidence for multidrug-resistant cells in human tumor cell populations.Cancer Treat Rep. 1983 Oct;67(10):883-8. Cancer Treat Rep. 1983. PMID: 6313186 Review.
Cited by
-
Protein expression profiles indicative for drug resistance of non-small cell lung cancer.Br J Cancer. 2002 Jul 29;87(3):251-7. doi: 10.1038/sj.bjc.6600463. Br J Cancer. 2002. PMID: 12177790 Free PMC article.
-
Antibody-directed therapy of multidrug-resistant tumor cells.Med Oncol Tumor Pharmacother. 1992;9(1):11-9. doi: 10.1007/BF02989648. Med Oncol Tumor Pharmacother. 1992. PMID: 1285219 Review.
-
Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4.Br J Cancer. 1991 Jul;64(1):87-9. doi: 10.1038/bjc.1991.245. Br J Cancer. 1991. PMID: 1677260 Free PMC article. No abstract available.
-
Correlations between natural resistance to doxorubicin, proliferative activity, and expression of P-glycoprotein 170 in human kidney tumor cell lines.Urol Res. 1990;18(5):309-12. doi: 10.1007/BF00300777. Urol Res. 1990. PMID: 1979457
-
Induced multidrug resistance in murine leukemia L1210 and associated changes in a surface-membrane glycoprotein.J Cancer Res Clin Oncol. 1989;115(1):17-24. doi: 10.1007/BF00391594. J Cancer Res Clin Oncol. 1989. PMID: 2563999 Free PMC article.